Christine Fox

Christine Fox

Executive Vice President, US CommercialatTeva Pharmaceutical Industries· In proxies 2024–2025

Pay in FY2025+13% from the year before

Christine Fox was paid $5.9M in FY2025 (Dec), up 13%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Teva Pharmaceutical Industries proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Teva Pharmaceutical IndustriesPublic company · 2 yr
    • Executive Vice President, US Commercial2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?